To the annoyance of some shareholders, Canopy Growth Corporation (TSE:WEED) shares are down a considerable 26% in the last month, which continues a horrid run for the company. Looking at the bigger picture, even after this poor month the stock is up 36% in the last year.
Although its price has dipped substantially, when almost half of the companies in Canada’s Pharmaceuticals industry have price-to-sales ratios (or “P/S”) below 1.1x, you may still consider Canopy Growth as a stock probably not worth researching with its 2.2x P/S ratio. However, the P/S might be high for a reason and it requires further investigation to determine if it’s justified.
Check out our latest analysis for Canopy Growth
What Does Canopy Growth’s Recent Performance Look Like?
Canopy Growth could be doing better as its revenue has been going backwards lately while most other companies…
